The purpose of the study is to demonstrate that reduction of unnecessary pacing provided by RYTHMIQ algorithm programed to ON in a pacemaker is associated with better clinical outcomes in bradycardia target population.
Study Type
OBSERVATIONAL
Enrollment
514
Combined event rate of all-cause mortality, cardiovascular hospitalizations and atrial fibrillation at 2 years in a specific Brady population implanted with BSC PM devices equipped with RYHTMIQ feature
Combined event rate of all-cause mortality, cardiovascular hospitalizations and atrial fibrillation at 2 years in a specific Brady population implanted with BSC PM devices equipped with RYHTMIQ feature compared to data from a cohort of subjects implanted with BSC PM without RYTHMIQ pooled from OPTI-MIND study.
Time frame: 2 years
Combined event rate of all-cause mortality, cardiovascular hospitalizations and atrial fibrillation at 2 years stratified per patient characteristics.
A multivariate model will be used to find the independent association with the combined primary endpoint, RYTHMIQ algorithm and other patient characteristics. Variables of interests include (but are not limited to): primary pacing indication (SND vs AVB), degree of AVB, age, gender, underlying disease, use of Betablockers, history of atrial fibrillation, LVEF, NYHA class, RV lead position, type of sensors used.
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Ziekenhuis Oost Limburg
Genk, Belgium
Hartcentrum Hasselt Jessa Ziekenhuis Campus Virga Jesse
Hasselt, Belgium
Regionshospitalet Herning
Herning, Denmark
Vejle Sygehus
Vejle, Denmark
Viborg Sygehus
Viborg, Denmark
CHRU Angers
Angers, France
CHRU de Clermont-Ferrand
Clermont-Ferrand, France
CHU Grenoble - Hopital Michallon
Grenoble, France
Hôpital la Roche sur Yon
La Roche-sur-Yon, France
Service de cardiologie, CHU Nancy-Brabois
Nancy, France
...and 29 more locations